Ignite Creation Date:
2025-12-24 @ 4:03 PM
Ignite Modification Date:
2026-01-01 @ 11:38 PM
Study NCT ID:
NCT02517866
Status:
COMPLETED
Last Update Posted:
2019-03-01
First Post:
2015-06-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Azilsartan Medoxomil in the Treatment of Essential Hypertension and Type 2 Diabetes in Asia
Sponsor:
Takeda
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-07-13
Start Date Type:
ACTUAL
Primary Completion Date:
2016-11-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-11-25
Completion Date Type:
ACTUAL
First Submit Date:
2015-06-24
First Submit QC Date:
None
Study First Post Date:
2015-08-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-10-04
Results First Submit QC Date:
None
Results First Post Date:
2019-03-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-29
Last Update Post Date:
2019-03-01
Last Update Post Date Type:
ACTUAL